HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Bartoloni Selected Research

Anticonvulsants (Antiepileptic Drugs)

1/2018Treating People With Epilepsy in Rural Low-Income Countries Is Feasible. Observations and Reflections From a "Real Life Experience" After a Long Lasting Intervention in the Rural Chaco.
8/2016Profile of adult and pediatric neurocysticercosis cases observed in five Southern European centers.
10/2009Natural history and mortality of chronic epilepsy in an untreated population of rural Bolivia: a follow-up after 10 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Bartoloni Research Topics

Disease

38Infections
04/2024 - 01/2007
29COVID-19
12/2023 - 01/2020
8Communicable Diseases (Infectious Diseases)
01/2023 - 03/2014
6Malaria
08/2022 - 08/2010
4Pneumonia (Pneumonitis)
10/2022 - 04/2009
4Neoplasms (Cancer)
01/2022 - 01/2013
4Fever (Fevers)
09/2021 - 06/2012
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 04/2013
3Bacterial Infections (Bacterial Infection)
09/2021 - 11/2020
3Meningitis
12/2019 - 06/2015
3Chickenpox
10/2018 - 06/2002
3Latent Tuberculosis
01/2018 - 04/2013
2Smallpox (Variola)
04/2024 - 01/2024
2Cytomegalovirus Infections (Inclusion Disease)
12/2023 - 04/2021
2Schistosomiasis (Bilharziasis)
11/2023 - 10/2018
2Sepsis (Septicemia)
01/2023 - 02/2018
2Inflammation (Inflammations)
01/2022 - 01/2022
2Leishmaniasis
01/2022 - 01/2021
2Visceral Leishmaniasis (Kala Azar)
11/2021 - 01/2021
2Cough
08/2020 - 04/2009
2Fibrosis (Cirrhosis)
07/2020 - 10/2018
2Strongyloidiasis
07/2020 - 06/2015
2Hepatitis
01/2019 - 05/2018
2Zika Virus Infection
01/2019 - 06/2016
2Parasitic Diseases (Parasitic Disease)
12/2018 - 08/2016
2Herpes Zoster
10/2018 - 06/2002
2Pain (Aches)
01/2018 - 12/2014
2Epilepsy (Aura)
01/2018 - 07/2005
2Tuberculosis (Tuberculoses)
01/2018 - 06/2017
2Falciparum Malaria (Plasmodium falciparum Malaria)
06/2012 - 08/2010
2Cross Infection (Nosocomial Infection)
02/2011 - 05/2009
2Seizures (Absence Seizure)
10/2009 - 04/2008
1Pulmonary Alveolar Proteinosis
02/2024
1Nocardia Infections
02/2024
1Poxviridae Infections
01/2024
1Mpox (monkeypox)
01/2024
1Edema (Dropsy)
01/2024
1Pericarditis
01/2024
1Myocarditis (Carditis)
01/2024
1Lyme Disease (Disease, Lyme)
01/2024

Drug/Important Bio-Agent (IBA)

8Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 04/2009
7VaccinesIBA
08/2023 - 08/2006
6AntibodiesIBA
04/2024 - 07/2005
6Antiviral Agents (Antivirals)IBA
01/2024 - 03/2017
6Immunoglobulin M (IgM)IBA
01/2022 - 12/2016
5Immunoglobulin G (IgG)IBA
04/2024 - 03/2007
5Oxygen (Dioxygen)IBA
10/2022 - 08/2020
5C-Reactive ProteinIBA
01/2022 - 09/2020
4ArtesunateIBA
08/2022 - 08/2010
4Biomarkers (Surrogate Marker)IBA
09/2021 - 09/2020
3Carbapenems (Carbapenem Antibiotics)IBA
02/2024 - 02/2018
3Valacyclovir (Valtrex)FDA LinkGeneric
12/2023 - 04/2021
3Praziquantel (Biltricide)FDA Link
11/2023 - 06/2019
3nirmatrelvir and ritonavir drug combinationIBA
08/2023 - 01/2023
3AntigensIBA
01/2023 - 04/2013
3Monoclonal AntibodiesIBA
10/2022 - 01/2018
3Quinine (Quinson)FDA Link
08/2022 - 08/2010
3Messenger RNA (mRNA)IBA
01/2022 - 01/2021
3CytokinesIBA
01/2022 - 06/2016
3Pentamidine (NebuPent)FDA LinkGeneric
11/2021 - 08/2020
3GoldIBA
02/2020 - 08/2014
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2018 - 10/2009
2Doxycycline (Periostat)FDA LinkGeneric
01/2024 - 12/2014
2tocilizumab (atlizumab)FDA Link
12/2023 - 01/2021
2molnupiravirIBA
08/2023 - 01/2023
2remdesivirIBA
01/2023 - 10/2022
2artemisinin (artemisinine)IBA
08/2022 - 01/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 04/2013
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2022
2ProcalcitoninIBA
01/2022 - 01/2016
2ruxolitinibIBA
11/2021 - 01/2021
2liposomal amphotericin BFDA Link
01/2021 - 08/2020
2cobicistat mixture with darunavirIBA
01/2021 - 08/2020
2CreatinineIBA
01/2021 - 01/2020
2SteroidsIBA
01/2021 - 01/2020
2LopinavirFDA Link
01/2021 - 08/2020
2Ritonavir (Norvir)FDA Link
01/2021 - 08/2020
2Meglumine AntimoniateIBA
01/2021 - 08/2020
2Interleukin-6 (Interleukin 6)IBA
09/2020 - 01/2020
2Ivermectin (Mectizan)FDA Link
07/2020 - 06/2015
2Immunoglobulin E (IgE)IBA
01/2020 - 03/2007
2Mebendazole (Anti-Worm)FDA Link
12/2018 - 01/2018
2Colistin (Coly-Mycin)FDA Link
11/2018 - 02/2018
2Immunoglobulins (Immunoglobulin)IBA
10/2018 - 01/2018
2Analgesics (Analgesic Drugs)IBA
01/2018 - 08/2016
2InterferonsIBA
04/2013 - 04/2013
2EnzymesIBA
01/2007 - 07/2005
1AutoantibodiesIBA
02/2024
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2024
1GadoliniumIBA
01/2024
13- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA
01/2024
1TroponinIBA
01/2024
1tecovirimatIBA
01/2024

Therapy/Procedure

22Therapeutics
12/2023 - 06/2012
4Liver Transplantation
07/2020 - 05/2018
4Hand Hygiene
05/2017 - 05/2009
3Critical Care (Surgical Intensive Care)
01/2021 - 11/2015
3Drug Therapy (Chemotherapy)
01/2020 - 01/2018
2Blood Transfusion (Blood Transfusions)
01/2022 - 11/2021
2Ambulatory Care (Outpatient Care)
01/2019 - 05/2018